APA (7th ed.) Citation

Saule Kubekova, Natalya Zagorulya, Yelena Ryb, Niyaz Malayev, & Aruzhan Abdilda. (2023). Chemotherapy and chemoembolization of patients with oncopathology as a risk factor for the development of myocardial dysfunction. National Scientific Medical Center.

Chicago Style (17th ed.) Citation

Saule Kubekova, Natalya Zagorulya, Yelena Ryb, Niyaz Malayev, and Aruzhan Abdilda. Chemotherapy and Chemoembolization of Patients with Oncopathology as a Risk Factor for the Development of Myocardial Dysfunction. National Scientific Medical Center, 2023.

MLA (9th ed.) Citation

Saule Kubekova, et al. Chemotherapy and Chemoembolization of Patients with Oncopathology as a Risk Factor for the Development of Myocardial Dysfunction. National Scientific Medical Center, 2023.